The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Despite mandated insurance coverage for breast reconstruction following mastectomy, health care costs are increasingly passed on to women through cost‐sharing arrangements and high‐deductible health plans. In this population‐based study, the authors assessed perceived financial and employment declines related to breast reconstruction following mastectomy.
Methods
Women with early‐stage...
Background
To inform patients who are in the process of selecting prostate cancer treatment, the authors compared disease‐specific function after external‐beam radiotherapy (EBRT) alone versus EBRT plus a low‐dose‐rate (LDR) brachytherapy boost (EBRT‐LDR).
Methods
For this prospective study, men who had localized prostate cancer in 2011 and 2012 were enrolled. Assessments at baseline, 0.5, 1, 3,...
Background
To the authors' knowledge, studies regarding risk perception among survivors of thyroid cancer are scarce.
Methods
The authors surveyed patients who were diagnosed with differentiated thyroid cancer from the Surveillance, Epidemiology, and End Results registries of Georgia and Los Angeles County (2632 patients; 63% response rate). The analytic cohort was defined by a ≤5% risk of disease...
Background
Treatment decisions for patients with early‐stage breast cancer often involve discussions with multiple oncology providers. However, the extent to which primary care providers (PCPs) are involved in initial treatment decisions remains unknown.
Methods
A stratified random sample of PCPs identified by newly diagnosed patients with early‐stage breast cancer from the Georgia and Los Angeles...
BACKGROUND
Little is known regarding whether growing awareness of the financial toxicity of a cancer diagnosis and its treatment has increased clinician engagement or changed the needs of current patients.
METHODS
The authors surveyed patients with early‐stage breast cancer who were identified through population‐based sampling from 2 Surveillance, Epidemiology, and End Results (SEER) regions and...
BACKGROUND
The omission of radiotherapy (RT) after lumpectomy is a reasonable option for many older women with favorable‐prognosis breast cancer. In the current study, we sought to evaluate patient perspectives regarding decision making about RT.
METHODS
Women aged 65 to 79 years with AJCC 7th edition stage I and II breast cancer who were reported to the Georgia and Los Angeles County Surveillance,...
BACKGROUND
To the authors' knowledge, the survival benefit of local therapy in the setting of advanced prostate cancer remains unknown. The authors investigated whether prostate‐directed treatment with either surgery or radiotherapy versus conservative treatment in the setting of locally advanced or metastatic disease was associated with improved survival within a cohort of men from the Centers for...
BACKGROUND
Many patients with breast cancer work for pay at the time of their diagnosis, and the treatment plan may threaten their livelihood. Understanding work experiences in a contemporary population‐based sample is necessary to inform initiatives to reduce the burden of cancer care.
METHODS
Women who were 20 to 79 years old and had been diagnosed with stage 0 to II breast cancer, as reported...
BACKGROUND
Little is known about how the individual decision styles and values of breast cancer patients at the time of treatment decision making are associated with the consideration of different treatment options and specifically with the consideration of contralateral prophylactic mastectomy (CPM).
METHODS
Newly diagnosed patients with early‐stage breast cancer who were treated in 2013‐2014...
BACKGROUND
Little is known about the size and characteristics of the decision‐support networks of women newly diagnosed with breast cancer and whether their involvement improves breast cancer treatment decisions.
METHODS
A population‐based sample of patients newly diagnosed with breast cancer in 2014 and 2015, as reported to the Georgia and Los Angeles Surveillance, Epidemiology, and End Results...
BACKGROUND
The authors examined racial/ethnic differences in patient perspectives regarding their breast cancer treatment experiences.
METHODS
A weighted random sample of women newly diagnosed with breast cancer between 2013 and 2015 in Los Angeles County and Georgia were sent surveys 2 months after undergoing surgery (5080 women; 70% response rate). The analytic sample was limited to patients...
BACKGROUND
Patient‐reported toxicities help to appraise the breast cancer treatment experience. Yet extant data come from clinical trials and health care claims, which may be biased. Using patient surveys, the authors sought to quantify the frequency, severity, and burden of treatment‐associated toxicities.
METHODS
Between 2013 and 2014, the iCanCare study surveyed a population‐based sample of...
BACKGROUND
The 21‐gene recurrence score (RS) assay stratifies early‐stage, estrogen receptor–positive breast cancer by recurrence risk. Few studies have examined the ways in which physicians use the RS to recommend adjuvant systemic chemotherapy or patients' experiences with testing and decision making.
METHODS
This study surveyed 3880 women treated for breast cancer in 2013‐2014; they were identified...
BACKGROUNDPoor accrual to cancer clinical trials may contribute to the lower improvement in survival observed for adolescents and young adults (AYAs) (those aged 15‐39 years) with cancer. This has been difficult to quantify without reliable mechanisms to link incident cases with study enrollments. Using unique resources available at their National Cancer Institute‐designated comprehensive cancer center,...
BACKGROUNDThe fertility of adolescent and young adult (AYA) patients with cancer can be threatened by treatments, but to the authors' knowledge little is known regarding the extent to which providers discuss this with patients or recommend fertility preservation, or the patient and physician characteristics associated with these interactions.
METHODSQuestionnaires from 459 AYA patients with cancer...
BACKGROUNDFollow‐up care is critical for childhood cancer survivors (CCS), who are at high risk for comorbidities and late effects of cancer treatments. Understanding the factors associated with maintaining follow‐up care is needed, especially for Hispanic CCS, who have been under‐represented in previous studies.
METHODSRisk factors and protective factors for receiving cancer‐related follow‐up care...
BACKGROUNDThe authors investigated the prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction in a contemporary, population‐based prostate cancer cohort. They also explored the associations between baseline function and age, comorbidity, and timing of baseline survey completion with respect to treatment.
METHODSThe Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR)...
BACKGROUND:Non‐Hodgkin lymphoma (NHL) is the fifth most common cancer among men and women. Patients with aggressive NHL receive intense medical treatments that can significantly compromise health‐related quality of life (HRQOL). However, knowledge of HRQOL and its correlates among survivors of aggressive NHL is limited.
METHODS:Self‐reported data on HRQOL (physical and mental function, anxiety, depression,...
BACKGROUND:Surveillance, Epidemiology, and End Results (SEER) registry data have been used to suggest underuse and disparities in receipt of radiotherapy. Prior studies have cautioned that SEER may underascertain radiotherapy but lacked adequate representation to assess whether underascertainment varies by geography or patient sociodemographic characteristics. The authors sought to determine rates...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.